Adam Houghton
Director/Board Member presso Kojin Therapeutics, Inc.
Profilo
Currently, Adam Houghton is Vice President for AbbVie Ventures.
Lord Houghton is also on the board of Kojin Therapeutics, Inc.
He previously was Senior Research Scientist at Procter & Gamble Co. and Senior Director & Head-Search & Evaluation at Biogen Corp.
Ltd.
Adam Houghton received an MBA from Xavier University and an undergraduate degree from Yale University.
Posizioni attive di Adam Houghton
| Società | Posizione | Inizio |
|---|---|---|
Kojin Therapeutics, Inc.
 Kojin Therapeutics, Inc. BiotechnologyHealth Technology Kojin Therapeutics, Inc. operates as a small-molecule therapeutics company. It focuses on translating deep biological insight into the plasticity of human cell states to develop therapeutics for cancer, fibrosis, ischemia and immune modulation. The company was founded by Benjamin Cravatt, Stephanie K. Dougan and Stuart L.Schreiber and is headquartered in the United States. | Director/Board Member | - |
Precedenti posizioni note di Adam Houghton
| Società | Posizione | Fine |
|---|---|---|
AbbVie Ventures LLC
 AbbVie Ventures LLC Investment ManagersFinance AbbVie Ventures LLC (AbbVie Ventures) is a venture capital firm, a subsidiary of AbbVie, Inc. founded in 2009. The firm is headquartered in North Chicago, Illinois. | Private Equity Investor | 01/09/2021 |
| Biogen Corp. Ltd. | Director-Back Office Operation | 28/02/2018 |
| ELI LILLY AND COMPANY | Director/Board Member | 28/02/2015 |
| PROCTER & GAMBLE COMPANY | Chief Tech/Sci/R&D Officer | 30/06/2005 |
Quench Bio, Inc.
 Quench Bio, Inc. BiotechnologyHealth Technology Quench Bio, Inc. develops therapies targeting innate immune pathways to treat life-threatening auto-immune and inflammatory diseases. The company was founded by Mark J. Tebbe, Mike Nolan, and Arturo Zychlinsky and is headquartered in Cambridge, MA. | Director/Board Member | - |
Formazione di Adam Houghton
| Xavier University | Masters Business Admin |
| Yale University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| PROCTER & GAMBLE COMPANY | Consumer Non-Durables |
| Aziende private | 4 |
|---|---|
| Biogen Corp. Ltd. | |
Quench Bio, Inc.
Quench Bio, Inc. BiotechnologyHealth Technology Quench Bio, Inc. develops therapies targeting innate immune pathways to treat life-threatening auto-immune and inflammatory diseases. The company was founded by Mark J. Tebbe, Mike Nolan, and Arturo Zychlinsky and is headquartered in Cambridge, MA. | Health Technology |
Kojin Therapeutics, Inc.
Kojin Therapeutics, Inc. BiotechnologyHealth Technology Kojin Therapeutics, Inc. operates as a small-molecule therapeutics company. It focuses on translating deep biological insight into the plasticity of human cell states to develop therapeutics for cancer, fibrosis, ischemia and immune modulation. The company was founded by Benjamin Cravatt, Stephanie K. Dougan and Stuart L.Schreiber and is headquartered in the United States. | Health Technology |
AbbVie Ventures LLC
AbbVie Ventures LLC Investment ManagersFinance AbbVie Ventures LLC (AbbVie Ventures) is a venture capital firm, a subsidiary of AbbVie, Inc. founded in 2009. The firm is headquartered in North Chicago, Illinois. | Finance |
- Borsa valori
- Insiders
- Adam Houghton
